Moreover, sustained systemic exposure to a TLR2 agonist protects mice from systemic C. albicans infection, and leads to an expansion of spleen HSPCs and myeloid cells; this protection is abrogated by immunodepletion of expanded HSPCs, indicating their protective role against infection. The gene discussed is TLR2; the disease is infection.